Bone Growth Stimulation Devices Market: Key Segments and Market Projections for 2030
Meticulous Research®—a renowned market intelligence and
consulting firm—has unveiled its latest report, titled "Bone Growth
Stimulators Market by Product (Stimulation Devices [External, Ultrasonic,
Implantable], Bone Morphogenetic Proteins, Platelet-Rich Plasma), Application
(Spinal Fusion, Fractures, Oral Surgeries), End User (Hospitals, ASCs) - Global
Forecast to 2030."
Download Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=3530
According to this publication, the global bone growth
stimulators market is projected to reach $1.94 billion by 2030,
growing at a CAGR of 4.9% from 2023 to 2030. This growth is driven by
the increasing demand for minimally invasive treatments, a surge in bone
fractures and spinal injuries, an aging population contributing to orthopedic
diseases and injuries, and a rising number of sports injuries. Additionally,
expanding hospitals and surgical centers worldwide, growing applications of
platelet-rich plasma (PRP), and opportunities in emerging markets are
propelling this market forward.
Market Segmentation
The bone growth stimulators market is segmented into Product,
Application, End User, and Geography:
1. By Product:
- Bone
Growth Stimulation Devices:
- External
Bone Growth Stimulators (Capacitive Coupling Devices, Combined Magnetic
Field Devices, Pulsed Electromagnetic Field Devices)
- Ultrasonic
Bone Growth Stimulators
- Implantable
Bone Growth Stimulators
- Bone
Morphogenetic Proteins
- Platelet-Rich
Plasma (PRP)
In 2023, the Bone Growth Stimulation Devices segment
is anticipated to hold the largest market share, primarily due to the rising
prevalence of bone fractures, high demand for cost-effective and minimally
invasive treatments, and the growing preference for non-invasive procedures.
2. By Application:
- Spinal
Fusion Surgeries
- Union
& Non-union Bone Fractures
- Oral
and Maxillofacial Surgeries
- Other
Applications
The Delayed Union & Non-union Bone Fractures segment
is expected to grow at the highest CAGR during the forecast period, driven by
an aging population prone to orthopedic conditions and challenges such as
insufficient nutrition and blood supply that delay bone healing. According to
the International Osteoporosis Foundation, osteoporosis causes 4.3 million
fragility fractures annually in Europe, with healthcare costs amounting to $59.01
million (€56 billion). By 2034, the population aged 75 and older is
projected to rise significantly, further escalating osteoporotic fractures.
3. By End User:
- Hospitals
& Specialized Clinics
- Ambulatory
Surgery Centers (ASCs)
- Other
End Users
In 2023, the Hospitals & Specialized Clinics segment
is expected to dominate the market. This dominance is attributed to the wide
availability of hospitals in urban and rural areas, increasing patient visits
for orthopedic care, and a growing pool of skilled medical professionals.
4. By Geography:
In 2023, North America is expected to hold the
largest share of the global market, driven by high healthcare expenditures, an
aging population, rapid technological advancements, and high adoption rates of
innovative healthcare products.
Key Players
Leading companies in the bone growth stimulators market
include:
- Orthofix
Medical Inc. (U.S.)
- Zimmer
Biomet Holdings, Inc. (U.S.)
- Medtronic,
plc (Ireland)
- Stryker
Corporation (U.S.)
- Johnson
& Johnson Private Limited (U.S.)
- DJO,
LLC (U.S.)
- Bioventus
LLC (U.S.)
- OssaTechnics
BV (Germany)
- Arthrex
GmbH (U.S.)
- Smith
& Nephew plc (U.K.)
- ITO
Co., Ltd. (Japan)
These companies are actively investing in product
innovation, expanding their global presence, and enhancing their portfolios to
address the rising demand for bone growth stimulators worldwide.
Quick Buy: https://www.meticulousresearch.com/Checkout/73200843
About Us
Meticulous Research® is a trusted partner for businesses
worldwide, providing actionable market intelligence to drive revenue growth and
strategic transformation. Supporting Fortune 500 companies and emerging
enterprises, we deliver insights that uncover forward-looking opportunities and
enable competitive advantage through syndicated reports, custom research, and
direct analyst engagement.
Each year, we conduct over 300 syndicated studies and manage
more than 60 consulting engagements across eight industries and 20+ geographic
markets. Our focus is on addressing the complex challenges faced by global
business leaders, helping them make informed decisions that drive sustainable
growth and operational excellence.
Contact Us
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email: sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
Follow Us for Updates:
- LinkedIn:
https://www.linkedin.com/company/meticulous-research
- Meticulous
Blog: https://meticulousblog.org/
Comments
Post a Comment